Table 2

 Disease activity levels at baseline and nine and 18 month follow-up

Dose reduction (n=121)Usual care (n=59)P*
Baseline
DAS28-CRP score <3.2113 (93)53 (90)-
DAS28-CRP score <2.692 (76)48 (81)-
2011 ACR/EULAR Boolean based remission31 (26)21 (36)-
9 month follow-up
DAS28-CRP score <3.289 (74)54 (92)0.005
DAS28-CRP score <2.673 (60)48 (81)0.005
2011 ACR/EULAR Boolean based remission22 (18)17 (29)0.104
18 month follow-up
DAS28-CRP score <3.2103 (85)53 (90)0.464
DAS28-CRP score <2.686 (71)47 (80)0.218
2011 ACR/EULAR Boolean based remission29 (24)24 (41)0.021

Data are number (%) of patients. ACR/EULAR=American College of Rheumatology/European League Against Rheumatism.

2, crude estimates without adjustments.